These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 27386833)

  • 1. A New Approach in Applying Systems Engineering Tools and Analysis to Determine Hepatocyte Toxicogenomics Risk Levels to Human Health.
    Gigrich J; Sarkani S; Holzer T
    J Comput Biol; 2017 Mar; 24(3):238-254. PubMed ID: 27386833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying qualitative differences in PPARα signaling networks in human and rat hepatocytes and their significance for next generation chemical risk assessment methods.
    McMullen PD; Bhattacharya S; Woods CG; Pendse SN; McBride MT; Soldatow VY; Deisenroth C; LeCluyse EL; Clewell RA; Andersen ME
    Toxicol In Vitro; 2020 Apr; 64():104463. PubMed ID: 31628012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxisome proliferator-activated receptor (PPAR)-gamma positively controls and PPARalpha negatively controls cyclooxygenase-2 expression in rat brain astrocytes through a convergence on PPARbeta/delta via mutual control of PPAR expression levels.
    Aleshin S; Grabeklis S; Hanck T; Sergeeva M; Reiser G
    Mol Pharmacol; 2009 Aug; 76(2):414-24. PubMed ID: 19483106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroxisome proliferator-activated receptor-alpha control of lipid and glucose metabolism in human white adipocytes.
    Ribet C; Montastier E; Valle C; Bezaire V; Mazzucotelli A; Mairal A; Viguerie N; Langin D
    Endocrinology; 2010 Jan; 151(1):123-33. PubMed ID: 19887568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A map of the PPARα transcription regulatory network for primary human hepatocytes.
    McMullen PD; Bhattacharya S; Woods CG; Sun B; Yarborough K; Ross SM; Miller ME; McBride MT; LeCluyse EL; Clewell RA; Andersen ME
    Chem Biol Interact; 2014 Feb; 209():14-24. PubMed ID: 24269660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A toxicogenomics-based parallelogram approach to evaluate the relevance of coumarin-induced responses in primary human hepatocytes in vitro for humans in vivo.
    Kienhuis AS; van de Poll MC; Dejong CH; Gottschalk R; van Herwijnen M; Boorsma A; Kleinjans JC; Stierum RH; van Delft JH
    Toxicol In Vitro; 2009 Sep; 23(6):1163-9. PubMed ID: 19527782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a toxicogenomics in vitro assay for the efficient characterization of compounds.
    Yang Y; Abel SJ; Ciurlionis R; Waring JF
    Pharmacogenomics; 2006 Mar; 7(2):177-86. PubMed ID: 16515397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The peroxisome proliferator-activated receptor α agonist, AZD4619, induces alanine aminotransferase-1 gene and protein expression in human, but not in rat hepatocytes: Correlation with serum ALT levels.
    Thulin P; Bamberg K; Buler M; Dahl B; Glinghammar B
    Int J Mol Med; 2016 Sep; 38(3):961-8. PubMed ID: 27430334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptomic signatures of peroxisome proliferator-activated receptor α (PPARα) in different mouse liver models identify novel aspects of its biology.
    Szalowska E; Tesfay HA; van Hijum SA; Kersten S
    BMC Genomics; 2014 Dec; 15(1):1106. PubMed ID: 25511156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PPAR-α agonist regulates amyloid-β generation via inhibiting BACE-1 activity in human neuroblastoma SH-SY5Y cells transfected with APPswe gene.
    Zhang H; Gao Y; Qiao PF; Zhao FL; Yan Y
    Mol Cell Biochem; 2015 Oct; 408(1-2):37-46. PubMed ID: 26092426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxisome proliferator-activated receptor alpha acts as a mediator of endoplasmic reticulum stress-induced hepatocyte apoptosis in acute liver failure.
    Zhang L; Ren F; Zhang X; Wang X; Shi H; Zhou L; Zheng S; Chen Y; Chen D; Li L; Zhao C; Duan Z
    Dis Model Mech; 2016 Jul; 9(7):799-809. PubMed ID: 27482818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-6 inhibits human peroxisome proliferator activated receptor alpha gene expression via CCAAT/enhancer-binding proteins in hepatocytes.
    Chew CH; Chew GS; Najimudin N; Tengku-Muhammad TS
    Int J Biochem Cell Biol; 2007; 39(10):1975-86. PubMed ID: 17616429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of toxicogenomics and traditional approaches to inform mode of action and points of departure in human health risk assessment of benzo[a]pyrene in drinking water.
    Moffat I; Chepelev N; Labib S; Bourdon-Lacombe J; Kuo B; Buick JK; Lemieux F; Williams A; Halappanavar S; Malik A; Luijten M; Aubrecht J; Hyduke DR; Fornace AJ; Swartz CD; Recio L; Yauk CL
    Crit Rev Toxicol; 2015 Jan; 45(1):1-43. PubMed ID: 25605026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of genomics in model in vitro systems.
    Casciano DA
    Adv Exp Med Biol; 2012; 745():210-20. PubMed ID: 22437820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of the comparison approach to open TG-GATEs: A useful toxicogenomics tool for detecting modes of action in chemical risk assessment.
    Heusinkveld HJ; Wackers PFK; Schoonen WG; van der Ven L; Pennings JLA; Luijten M
    Food Chem Toxicol; 2018 Nov; 121():115-123. PubMed ID: 30096367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Baseline and genotoxic compound induced gene expression profiles in HepG2 and HepaRG compared to primary human hepatocytes.
    Jetten MJ; Kleinjans JC; Claessen SM; Chesné C; van Delft JH
    Toxicol In Vitro; 2013 Oct; 27(7):2031-40. PubMed ID: 23911569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential gene expression in mouse primary hepatocytes exposed to the peroxisome proliferator-activated receptor alpha agonists.
    Guo L; Fang H; Collins J; Fan XH; Dial S; Wong A; Mehta K; Blann E; Shi L; Tong W; Dragan YP
    BMC Bioinformatics; 2006 Sep; 7 Suppl 2(Suppl 2):S18. PubMed ID: 17118139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PPARalpha agonists inhibit nitric oxide production by enhancing iNOS degradation in LPS-treated macrophages.
    Paukkeri EL; Leppänen T; Sareila O; Vuolteenaho K; Kankaanranta H; Moilanen E
    Br J Pharmacol; 2007 Dec; 152(7):1081-91. PubMed ID: 17891158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PPARalpha ligands inhibit radiation-induced microglial inflammatory responses by negatively regulating NF-kappaB and AP-1 pathways.
    Ramanan S; Kooshki M; Zhao W; Hsu FC; Robbins ME
    Free Radic Biol Med; 2008 Dec; 45(12):1695-704. PubMed ID: 18852043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-related differences in the effects of α and γ peroxisome proliferator-activated receptor subtype agonists on endothelial vasodilation in human microvessels.
    Angulo J; Vallejo S; El Assar M; García-Septiem J; Sánchez-Ferrer CF; Rodríguez-Mañas L
    Exp Gerontol; 2012 Sep; 47(9):734-40. PubMed ID: 22776133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.